contact@asploro.com
Diabetes Research: Open Access
Diabetes Research: Open Access

Diabetes Research: Open Access is an Open Access Journal which releases Scholarly Articles featuring the content about Diabetes and Endocrinology.

The extent of the journal incorporates endocrine organs, hormonal discharges, hormonal receptors and the hormone controlled metabolic pathways. It also includes the clinical investigation of disorders related to Diabetes.

The articles including diabetes featured symptoms, causes, pathophysiology, conclusion, treatment and prevention of diabetes and investigation in the field of diabetic research like organ transplantation, tissue recovery and helpful developments. The articles cover insulin dependent diabetes, insulin independent diabetes, insulin metabolism. It also enlists latest research conducted in the field of various diabetes related complications like diabetic retinopathy and diabetic neuropathy.

Submit Manuscript

Submit manuscript as an e-mail attachment to the Editorial Office at diabetes@emedscionline.com or through online at Submit Manuscript

Latest Papers

In this editorial, I would like to go through some philosophical aspects in conceptual formulations. Diabetes has been defined as part of metabolic syndrome. Diabetes is associated with insulin deficiency either in concentration or function. This is the classical and traditional picture associated with diabetes type 2. Diabetic complications are also associated with these concepts involving the metabolic points of view.

Congratulations on the inaugural issue of Diabetes Research: Open Access (DROA). Across the world, the necessity of medical practice and research concerning diabetes has been more emphasized. The significant role of this journal will be expected from now.

In recent years, lifestyle-related diseases such as obesity and diabetes have increased worldwide as non-communicable diseases (NCDs). Statistically, 71% of 57 million world deaths in 2016 were from NCDs. The United Nations meeting on NCSs reviewed the global progress for the prevention and control of NCDs, and proposed countdown 2030 for reduction of the burden of NCDs. Among NCDs, diabetes and hypertension have been prevalent and important to manage in the clinical practice.